Description: ChemomAb Ltd. develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. The company is based in Tel Aviv, Israel.
Home Page: www.chemomab.com
CMMB Technical Analysis
Building 7
Tel Aviv,
6158002
Israel
Phone:
972 77 331 0156
Officers
| Name | Title |
|---|---|
| Dr. Dale R. Pfost Ph.D. | Chairman & CEO |
| Dr. Adi Mor George Ph.D. | Co-Founder, Chief Scientific Officer & Exec. Director |
| Mr. Donald R. Marvin MBA | CFO, Exec. VP & COO |
| Barbara Lindheim | Consulting VP of Investor & PR, Strategic Communications |
| Mr. Mitchell Lawrence Jones M.D., Ph.D. | VP of Corp. Devel. & Strategy |
| Dr. Matthew Frankel M.B.A., M.D. | Chief Medical Officer & VP of Drug Devel. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 13.0039 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6199 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2019-02-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 20 |